US Patent 8987435 Oligomeric compounds and methods
Patent 8987435 was granted and assigned to Ionis Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+266 characters)
Article
Patent abstract
The present invention provides oligomeric compounds and uses thereof. In certain embodiments, such oligomeric compounds are useful as antisense compounds. Certain such antisense compounds are useful as RNase H antisense compounds or as RNAi compounds.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08987435 Oligomeric compounds and methods US Patent 8987435 Oligomeric compounds and methods
Infobox
Patent Number
0898743500
Patent Number
898743500
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
089874350
Date of Patent
March 24, 2015
0Patent Application Number
131257510
Date Filed
October 23, 2009
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
089874350
Date of Patent
March 24, 2015
0Patent Application Number
131257510
Date Filed
October 23, 2009
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08987435 Oligomeric compounds and methods
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08987435
Date of patent
March 24, 2015
Patent application number
13125751
Date Filed
October 23, 2009
Patent primary examiner
Find more entities like US Patent 8987435 Oligomeric compounds and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
